SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
|---|---|---|
| DIMERIX LIMITED | 01/12/2015 | |
| SUN BIOMEDICAL LIMITED | 19/12/2007 | 01/12/2015 |
| HARRINGTON GROUP LIMITED | 09/05/1997 | 19/12/2007 |
| AUSFOR LIMITED | 09/05/1997 |
Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001
Tel : 1300 288 664 or +61 2 9698 5414The suspension of trading in the securities of Dimerix Limited ("˜DXB') will be lifted immediately following the release by DXB of an announcement regarding a capital raising. | 04/05/2023 |
The company releases an Investor Presentation. | 04/05/2023 |
The company releases a notice of proposed issue of securities. | 04/05/2023 |
Dimerix is seeking to raise $12 million, through a combination of an entitlement offer and convertible notes, with an option for up to a further $8.5 million in convertible notes. The entitlement offer seeks to raise up to approximately $8.56 million through a partially underwritten non-renounceable entitlement offer to shareholders of 1 New Share for every 3 Shares held by eligible shareholders on the Record Date at an issue price of $0.08 per New Share. Approximately $4.06 million of the entitlement offer is underwritten. Every two shares under the Entitlement Offer will be accompanied by two free-attaching options in total. Commitment for full entitlement uptake and sub-underwriting of a portion of shortfall from substantial shareholder Mr Peter Meurs and directors Dr Nina Webster and Dr Sonia Poli. Firm sub-underwriting commitments from international institutional and sophisticated investors. Funds raised to continue the Company's Phase 3 FSGS clinical program past 1st interim data, including clinical, manufacturing and partnering activities. Dimerix has entered into a Convertible Securities Agreement with Mercer Street Global Opportunity Fund, LLC, a US-based investment fund to access up to $12 million of funding, with an initial tranche of $3.5 million ($1.9 million of which is subject to shareholder approval) and a further optional tranche of up to $8.5 million by mutual agreement. | 04/05/2023 |
The securities of Dimerix Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of DXB, pending the release of an announcement regarding a capital raise. | 03/05/2023 |
The suspension of trading in the securities of Dimerix Limited will be lifted immediately, following receipt of an announcement regarding the proposed capital raising undertaken by the Company. | 06/12/2017 |
The company releases a notice to shareholders regarding the non-renounceable entitlement offer. Dimerix is pleased to confirm it has received firm commitments to participate in the Entitlement Offer from major shareholders, Directors and management to the amount of at least $800,000. | 06/12/2017 |
An entitlement offer booklet was also released by the company. | 06/12/2017 |
The company releases an entitlement offer cleansing notice in relation to the 1 for 2 offer. | 06/12/2017 |
The company intends to undertake a 1 for 2 pro rata non-renounceable entitlement offer of fully paid ordinary shares in Dimerix to raise approximately $5,524,906. The offer price for the Entitlement Offer will be 12 cents per New Share. The Entitlement Offer Price represents a 31% discount to the 15 day VWAP to 30 November 2017 of Dimerix shares. | 06/12/2017 |
The securities of Dimerix Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. | 05/12/2017 |
we understand that on or about this date the company consolidated its shares 1 for 20 | 31/10/2017 |
we understand that on or about this date the company consolidated its shares 1 for 20 | 31/10/2017 |
name changed from Sun Biomedical Limited | 01/12/2015 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 27/03/2024 | Nina Webster | 33,000 | $0.310 | $10,230.00 |
| 07/09/2018 | Nina Webster | 45,000 | $0.110 | $4,950.00 |
| 25/05/2018 | David Franklyn | 200,000 | $0.100 | $20,000.00 |
| 24/05/2018 | James Williams | 50,000 | $0.100 | $5,000.00 |
| 28/02/2017 | Sonia Poli | 2,600,000 | $0.008 | $20,800.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Mark Diamond | Chairman | 01/12/2023 |
| Sonia Poli | Managing Director | 05/07/2015 |
| Nina Webster | Managing Director, CEO | 27/08/2018 |
| Hamish George | CFO, Company Secretary | 06/05/2019 |
| Clinton Snow | Non Exec Director | 01/05/2023 |
| Hugh Alsop | Non Exec Director | 01/05/2017 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
